P3 Health Partners SPAC Presentation Deck
Summary Risk Factors (Cont'd)
Risks Related to the Business Combination and the Private Placement
Except as otherwise noted below, references to "we" and "our" below refer to Foresight
Directors of Foresight have potential conflicts of interest in recommending that our stockholders vote in favor of approval of the Business Combination.
Foresight's initial stockholders, officers and directors have agreed to vote in favor of the Business Combination, regardless of how our public stockholders vote.
Foresight's sponsors, directors, officers, advisors, and their affiliates may enter into certain transactions, including purchasing shares or warrants from public stockholders, which may influence a vote on the Business Combination
and reduce the public "float" of our securities.
●
●
●
Subsequent to the consummation of the Business Combination, we may be required to take write-downs or write-offs, restructuring and impairment or other charges that could have a significant negative effect on our financial
condition, results of operations and the price of our securities, which could cause you to lose some or all of your investment.
We may invest or spend the proceeds of the Business Combination and private placement in ways with which the investors may not agree or in ways which may not yield a return.
Each of Foresight and P3 Health have incurred and will incur substantial costs in connection with the Business Combination, private placement and related transactions, such as legal, accounting, consulting, and financial advisory
fees, which will be paid out of the proceeds of the Business Combination and the private placement.
There can be no assurance that the common stock issued in connection with the Business Combination will be approved for listing on Nasdaq following the closing, or that we will be able to comply with the continued listing standards
of Nasdaq.
The ability of Foresight's public stockholders to exercise redemption rights with respect to a large number of shares could deplete Foresight's trust account prior to the Business Combination and thereby diminish the amount of
working capital of the combined company.
Uncertainty about the effect of the Business Combination may affect our ability and the ability of P3 Health to retain key employees and integrate management structures and may materially impact the management, strategy, and
results of our operation as a combined company.
42
P3View entire presentation